Want to see PPCB full AI Analyst Report?
Propanc Biopharma (PPCB) Income Statement
Propanc Biopharma Income Statement
Last quarter (Q4 2026), Propanc Biopharma's total revenue was $0.00. In Q4, Propanc Biopharma's net income was $-4.57M. See Propanc Biopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 18.19M | $ 57.28M | $ 1.54M | $ 1.78M | $ 1.99M | |
| Depreciation and Amortization | $ 22.70K | $ 20.19K | $ 21.66K | $ 1.67K | $ 1.99K |
| $ -18.41M | $ -58.34M | $ -1.26M | $ -2.26M | $ -2.14M | |
| $ -18.19M | $ -57.28M | $ -1.54M | $ -1.78M | $ -1.99M | |
| $ -677.14K | $ -1.65M | $ -413.61K | $ -1.01M | $ -722.19K | |
| $ -18.86M | $ -58.92M | $ -1.95M | $ -2.79M | $ -2.71M | |
| $ -18.86M | $ -58.92M | $ -1.82M | $ -2.66M | $ -2.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -176.16 | $ -3712.24 | $ -0.02 | $ -26974080.43 | $ -738454474.53 |
| Diluted EPS | $ -176.16 | $ -3712.24 | $ -0.02 | $ -26974080.43 | $ -738454474.53 |
| Weighted Average Shares Outstanding | 112.37K | 15.87K | 85.05M | ― | ― |
| Weighted Average Shares Outstanding (Diluted) | 112.37K | 15.87K | 85.05M | ― | ― |
Currency in USD
